Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant
FranceStudy on Reduced Antiplatelet Therapy with Acetylsalicylic Acid and Clopidogrel for Patients with Coronary Artery Disease After Stent Implantation
FranceStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
FranceLong-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials
FranceStudy on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis
FranceStudy of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors
FranceStudy of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
FranceStudy on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
FranceStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
FranceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
FranceStudy on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
FranceStudy of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
